Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract, with KIT mutations ...
The stem cell factor (SCF) receptor KIT is a type III receptor protein tyrosine kinase (RTK) primarily located in the plasma membrane (PM) of the interstitial cells of Cajal in the gastrointestinal ...
Progressing lesions of 25 patients with GISTs refractory to ripretinib were sequenced for KIT resistance mutations. Resistant genotypes were validated and characterized using novel cell line models ...
The optimal duration of adjuvant imatinib has yet to be determined, and clinical trials are ongoing to address this. KIT-directed tyrosine kinase inhibitors (TKIs) are the key treatment for advanced ...
Mesothelioma is a highly aggressive and lethal tumor which most frequently results from asbestos exposure. Mesothelioma has been subdivided into three histological types: epithelioid (the most common: ...
Sweet sabotage: How a sugar-modifying enzyme fuels gastrointestinal stromal tumor’s deadliest driver
Gastrointestinal stromal tumors (GISTs) are primarily driven by mutations in the KIT receptor, yet many patients eventually ...
The development of new therapeutics targeting protein kinases is crucial in the fight against diseases like cancer. Kinase drug discovery programs rely on the precise characterization and screening of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results